An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma
Background: Nowadays, clinical treatment outcomes of patients with hepatocellular carcinoma (HCC) have been improved.However, due to the complexity of the molecular mechanisms, the recurrence rate and mortality in HCC inpatients are still at a high level.Therefore, there is an urgent need in screening biomarkers of HCC to show therapeutic effects a